Journal of Neurochemistry · 1994 · 38 citations · 61 references
Life SciencesNeurobiologyNeuroscienceCell SignalingNeurochemistrySignal TransductionAstrocyte BiologyGlial Cell Molecular BiologyNervous TissueNeurotransmissionNeurotransmitter ReceptorsAstrocyte PhysiologyAstrocyte-mediated Neurochemical RegulationG Protein-coupled Neuropeptide ReceptorsMolecular ReceptorsNeuropeptide Receptor SubtypesReceptorsTranscripts
We have compared the effects of atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP), and C-type natriuretic peptide (CNP) on the accumulation of cyclic GMP (cGMP) in secondary cultures of rat astrocytes. The order of potency of these peptides was CNP > ANP > BNP, which would be compatible with a predominance of guanylate cyclase B (GC-B)- versus guanylate cyclase A (GC-A)-type receptors in these cells. Accordingly, we found by northern blot analysis that the mRNA transcripts of GC-B were much more abundant in astrocytes than the transcripts of GC-A. In addition, astrocytes from diencephalon accumulated two times more cGMP in response to CNP than astrocytes from cortex. Binding experiments with 125I-labeled ANP or [Tyro]-CNP established that these ligands recognized only clearance-type receptors on astrocytes. However, the number of binding sites was approximately 100 times higher in astrocytes from cortex than in astrocytes from diencephalon and thus was inversely correlated to the amplitude of the cGMP response in the same cells. We found no further evidence for differences in the levels of GC-B receptors in astrocytes from the two regions because (a) the abundance of GC-B mRNA was similar and (b) there was no difference in particulate guanylate cyclase activity in astrocytes from each region. In addition, occupancy of clearance receptors with C-ANP4-23 did not affect the accumulation of cGMP in response to CNP; this makes it unlikely that the differences in cGMP responsiveness can be accounted for by binding and sequestration of CNP to the clearance receptors.(ABSTRACT TRUNCATED AT 250 WORDS)
61
A membrane form of guanylate cyclase is an atrial natriuretic peptide receptor
Michael Chinkers, David L. Garbers, Ming‐Shi Chang et al. · Nature · 1989 · 1K citations
Physiological Role of Silent Receptors of Atrial Natriuretic Factor
Thomas Maack, Muneya Suzuki, Fernando Antônio de Almeida et al. · Science · 1987 · 940 citations
Medicine, Pharmacology, Physiology +14
Selective Activation of the B Natriuretic Peptide Receptor by C-Type Natriuretic Peptide (CNP)
Kerry J. Koller, David Lowe, Gregory L. Bennett et al. · Science · 1991 · 731 citations